Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Duo Xu

Has grant

Assistant Researcher

University of California, Los Angeles

United States

Research Interests

Explore related searches

Professors in United States Professors in Cell Biology Cell Biology professors in United States

Recent Grants

Grant: Close

Dissecting the tumor metabolism in pleural mesothelioma

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Metabolic study of tumor suppressor NF2 in pleural mesothelioma

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Study of ‘Warburg effect’ in pleural mesothelioma under metabolic stress

Open Date: 2022-01-01

Close Date: 2023-12-01

Articles (8)

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (6)

Sabina Berezowska

Associate Professor, Médecin cheffe

SWITZERLAND

View details

Ren-Wang Peng

Group Leader/Principal Investigator

University Hospital of Bern

SWITZERLAND

View details

Thomas Michael Marti

Group Leader

University Hospital of Bern

SWITZERLAND

View details

Nicola Zamboni

Adj. Prof

ETH Zürich

SWITZERLAND

View details

Adrian F. Ochsenbein

SWITZERLAND

View details

Balazs Hegedus

University Hospital Essen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Duo Xu

Research Interests

Explore related searches

Recent Grants

Articles (8)

Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

De novo pyrimidine synthesis is a collateral metabolic vulnerability in <i>NF2</i>-deficient mesothelioma

Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer.

Crispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesothelioma

NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma

Collaborators (6)

Sabina Berezowska

Ren-Wang Peng

Thomas Michael Marti

Nicola Zamboni

Adrian F. Ochsenbein

Balazs Hegedus

Make your next move.